Atlas Trials

Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib

Clinical trial NCT05473468 · UNKNOWN

Trial details

NCT number
NCT05473468
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2022-08-26
Primary completion
2022-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.